SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001532176-13-000022
Filing Date
2013-08-06
Accepted
2013-08-06 07:10:00
Documents
19
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q regn-63013x10q.htm 10-Q 1670563
2 MT. PLEASANT LEASE, BY AND BETWEEN BMR-LANDMARK AT EASTVIEW LLC AND REGENERON regn-ex_101x6302013x10q.htm EX-10.1 884794
3 ELEVENTH AMENDMENT TO TARRYTOWN LEASE regn-ex_102x6302013x10q.htm EX-10.2 69447
4 TWELFTH AMENDMENT TO TARRYTOWN LEASE regn-ex_103x6302013x10q.htm EX-10.3 61242
5 THIRTEENTH AMENDMENT TO TARRYTOWN LEASE regn-ex_104x6302013x10q.htm EX-10.4 107526
6 FIRST AMENDMENT TO REGENERON AND SANOFI LICENSE AND COLLABORATION AGREEMENT regn-ex_105x6302013x10q.htm EX-10.5 105447
7 LETTER AGREEMENT - REGENERON AND AVENTIS PHARMACEUTICALS regn-ex_106x6302013x10q.htm EX-10.6 33993
8 AMENDED AND RESTATED LICENSE AND SETTLEMENT AGREEMENT - GENENTECH AND REGENERON regn-ex_107x6302013x10q.htm EX-10.7 186065
9 NON-EXCLUSIVE LICENSE AND SETTLEMENT AGREEMENT regn-ex_108x6302013x10q.htm EX-10.8 193322
10 AGREEMENT BETWEEN BAYER PHARMA AG, BAYER AUSTRALIA LIMITED, REGN, AND GENENTECH regn-ex_109x6302013x10q.htm EX-10.9 176388
11 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) regn-ex_311x6302013x10q.htm EX-31.1 15228
12 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) regn-ex_312x6302013x10q.htm EX-31.2 15681
13 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 regn-ex_32x6302013x10q.htm EX-32 6693
  Complete submission text file 0001532176-13-000022.txt   12691808

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE DOCUMENT regn-20130630.xml EX-101.INS 1263567
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20130630.xsd EX-101.SCH 34010
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT regn-20130630_cal.xml EX-101.CAL 65473
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT regn-20130630_def.xml EX-101.DEF 208400
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20130630_lab.xml EX-101.LAB 467513
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20130630_pre.xml EX-101.PRE 259197
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 131011815
SIC: 2834 Pharmaceutical Preparations